Patents by Inventor Yoon S. Cho-Chung

Yoon S. Cho-Chung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7838305
    Abstract: The present invention relates to compositions and methods for the detection of anti-ECPKA autoantibodies in a biological sample, and to the use of such compositions and methods in the diagnosis of cancer in humans and non-human mammals.
    Type: Grant
    Filed: March 7, 2005
    Date of Patent: November 23, 2010
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Yoon S. Cho-Chung, Christina Chung, legal representative
  • Publication number: 20090123948
    Abstract: The present invention relates to compositions and methods for the detection of anti-ECPKA autoantibodies in a biological sample, and to the use of such compositions and methods in the diagnosis of cancer in humans and non-human mammals.
    Type: Application
    Filed: March 7, 2005
    Publication date: May 14, 2009
    Applicant: Govt. of the U.S. of America, represented by the Sec., Dept. of Health and Human Services
    Inventors: Yoon S. Cho-Chung, Christina Chung
  • Patent number: 6060310
    Abstract: The present invention provides compositions with high affinity for a target transcription factor, that can be introduced into cells as decoy cis-elements to bind the factor and alter gene expression. Specifically, the present invention provides nucleic acid molecules that compete with cAMP response element (CRE) enhancers for binding to transcription factors.
    Type: Grant
    Filed: November 24, 1997
    Date of Patent: May 9, 2000
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventor: Yoon S. Cho-Chung
  • Patent number: 5691317
    Abstract: Antisense oligonucleotides of human regulatory subunit RI-alpha of cAMP-dependent protein kinases are disclosed along with pharmaceutical compositions containing these oligonucleotides as the active ingredients. These antisense oligonucleotides are useful for inhibiting the growth of cancer.
    Type: Grant
    Filed: February 2, 1995
    Date of Patent: November 25, 1997
    Inventor: Yoon S. Cho-Chung
  • Patent number: 5627158
    Abstract: Antisense oligonucleotides of human regulatory subunit RI-alpha of cAMP-dependent protein kinases are disclosed along with pharmaceutical compositions containing these oligonucleotides as the active ingredients. These antisense oligonucleotides are useful for inhibiting the growth of cancer.
    Type: Grant
    Filed: May 14, 1993
    Date of Patent: May 6, 1997
    Inventor: Yoon S. Cho-Chung
  • Patent number: 5271941
    Abstract: Antisense oligonucleotides of human regulatory subunit RI-alpha of cAMP-dependent protein kinases are disclosed along with pharmaceutical compositions containing these oligonucleotides as the active ingredients. These antisense oligonucleotides have been shown to inhibit the growth of several cancer cell lines including HL-60, human colon carcinoma LS-174T, neuroblastoma cells, breast cancer cells, and gastric carcinoma cells. In addition, these oligonucleotides can inhibit the growth of human colon carcinoma cells transplanted in athymic mice.
    Type: Grant
    Filed: May 20, 1991
    Date of Patent: December 21, 1993
    Inventor: Yoon S. Cho-Chung